Well there is a reflection of the quality of management in charge at vhl. I swear some of the quality posters on hc know more about some of these companys than the blokes running them but all of that aside i see an oppurtunity here. From the ann today i liked this comment
" The Company notes that Transgene is expected to announce shortly that Novartis will exercise a licence for further development of TG4010."
The question is what is this worth to the company bearing in mind the first $8,269,756 goes to the Voluntary Administrators for distribution to the Creditors Trust.
PS
Cadence should send them an email and bring them up to speed
Well there is a reflection of the quality of management in...
Add to My Watchlist
What is My Watchlist?
